Literature DB >> 15140955

Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.

Martin L Moore1, Erin L McKissic, Corrie C Brown, John E Wilkinson, Katherine R Spindler.   

Abstract

Mouse adenovirus type 1 (MAV-1) infection of B-cell-deficient and Bruton's tyrosine kinase (Btk)-deficient mice resulted in fatal disseminated disease resembling human adenovirus infections in immunocompromised patients. Mice lacking B cells or Btk were highly susceptible to acute MAV-1 infection, in contrast to controls and mice lacking T cells. To our knowledge, this is the first demonstration that mice with an X-linked immunodeficiency phenotype (Btk deficient) are susceptible to virus-induced disease. Mice lacking B cells or Btk on a C57BL/6 background succumbed with encephalomyelitis, hepatitis, and lymphoid necrosis. Mice lacking B cells on a BALB/c background succumbed with enteritis and hepatitis. Survival of acute MAV-1 infection correlated with early T-cell-independent neutralizing antibody and T-cell-independent antiviral immunoglobulin M. Treatment of MAV-1-infected Btk(-/-) mice 4 to 9 days postinfection with antiserum harvested 6 to 9 days postinfection from MAV-1-infected Btk(+/+) mice was therapeutic. Our findings implicate a critical role for B-cell function in preventing disseminated MAV-1 infection, particularly production of early T-cell-independent antiviral immunoglobulin M.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140955      PMCID: PMC415807          DOI: 10.1128/JVI.78.11.5584-5590.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Acute adenovirus hepatitis in liver transplant recipients.

Authors:  B Cames; J Rahier; G Burtomboy; J de Ville de Goyet; R Reding; M Lamy; J B Otte; E M Sokal
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

2.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

3.  Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections.

Authors:  C Blanke; C Clark; E R Broun; G Tricot; I Cunningham; K Cornetta; A Hedderman; R Hromas
Journal:  Am J Med       Date:  1995-09       Impact factor: 4.965

4.  Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells.

Authors:  J W McCarrick; J R Parnes; R H Seong; D Solter; B B Knowles
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

5.  Neutropenia associated with X-linked agammaglobulinaemia.

Authors:  C Kozlowski; D I Evans
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

6.  Mice lacking major histocompatibility complex class I and class II molecules.

Authors:  M J Grusby; H Auchincloss; R Lee; R S Johnson; J P Spencer; M Zijlstra; R Jaenisch; V E Papaioannou; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

8.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

Authors:  P Mombaerts; A R Clarke; M A Rudnicki; J Iacomini; S Itohara; J J Lafaille; L Wang; Y Ichikawa; R Jaenisch; M L Hooper
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

9.  Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus.

Authors:  J Chen; M Trounstine; F W Alt; F Young; C Kurahara; J F Loring; D Huszar
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

10.  Increasing incidence of adenovirus disease in bone marrow transplant recipients.

Authors:  P Flomenberg; J Babbitt; W R Drobyski; R C Ash; D R Carrigan; G V Sedmak; T McAuliffe; B Camitta; M M Horowitz; N Bunin
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

View more
  28 in total

1.  Characterization of a permissive epitope insertion site in adenovirus hexon.

Authors:  Michael J McConnell; Xavier Danthinne; Michael J Imperiale
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  More than one way to TRIM a capsid.

Authors:  Jeremy Luban
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-13       Impact factor: 11.205

Review 3.  Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host.

Authors:  Silvio Hemmi; Katherine R Spindler
Journal:  FEBS Lett       Date:  2019-12-06       Impact factor: 4.124

4.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice.

Authors:  Megan C Procario; Rachael E Levine; Mary K McCarthy; Eunnie Kim; Lingqiao Zhu; Cheong-Hee Chang; Marc B Hershenson; Jason B Weinberg
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

7.  A Protective Role for Interleukin-1 Signaling during Mouse Adenovirus Type 1-Induced Encephalitis.

Authors:  Luiza A Castro-Jorge; Carla D Pretto; Asa B Smith; Oded Foreman; Kelly E Carnahan; Katherine R Spindler
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

8.  Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1.

Authors:  Amanda R Welton; Elissa J Chesler; Carla Sturkie; Anne U Jackson; Gwen N Hirsch; Katherine R Spindler
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Mouse adenovirus type 1 infection of natural killer cell-deficient mice.

Authors:  Amanda R Welton; Lisa E Gralinski; Katherine R Spindler
Journal:  Virology       Date:  2007-12-21       Impact factor: 3.616

Review 10.  Innate immunity to adenovirus.

Authors:  Rodinde Hendrickx; Nicole Stichling; Jorien Koelen; Lukasz Kuryk; Agnieszka Lipiec; Urs F Greber
Journal:  Hum Gene Ther       Date:  2014-04-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.